Seven novel 3-(2-(heterocyclo-2-ylthio)ethoxy)benzo[d]isothiazoles(3a^3g) have been synthesized and characterized by ESI-MS and 1H and 13 C NMR spectra. The crystal structures of 3a and 3g have been determined. ...Seven novel 3-(2-(heterocyclo-2-ylthio)ethoxy)benzo[d]isothiazoles(3a^3g) have been synthesized and characterized by ESI-MS and 1H and 13 C NMR spectra. The crystal structures of 3a and 3g have been determined. Compound 3a(C(11)H(11)N5O1S2) belongs to the monoclinic system and 3g(C(12)H(11)N3OS3) to the triclinic system. The title compounds show excellent in vitro antibacterial activities, with the minimum inhibitory concentrations varying from 4 to 32 ug/m L.展开更多
基金Supported by the Key Science and Technology Plan Projects of Hainan Province(No.ZDYF20160954)Natural Science Foundation of Hainan Province(No.20162025)Research Project of Hainan Provincial Department of Education(HNKY2014-39)
文摘Seven novel 3-(2-(heterocyclo-2-ylthio)ethoxy)benzo[d]isothiazoles(3a^3g) have been synthesized and characterized by ESI-MS and 1H and 13 C NMR spectra. The crystal structures of 3a and 3g have been determined. Compound 3a(C(11)H(11)N5O1S2) belongs to the monoclinic system and 3g(C(12)H(11)N3OS3) to the triclinic system. The title compounds show excellent in vitro antibacterial activities, with the minimum inhibitory concentrations varying from 4 to 32 ug/m L.